ClinConnect ClinConnect Logo
Search / Trial NCT01982890

Telomeres and T-cell Receptor Excision Circles (TRECs) From Peripheral Blood in Normal Subjects Over Time

Launched by UNIVERSITÉ DE SHERBROOKE · Nov 6, 2013

Trial Information

Current as of July 04, 2025

Enrolling by invitation

Keywords

Telomere Length Longitudinal Observation

ClinConnect Summary

It is difficult to establish early on the prognosis of patients with recent-onset polyarthritis. We want to know if we can use the length of telomeres in peripheral blood cells at baseline as a novel prognostic marker.

In order to be able to interpret our observations in arthritis patients over time, we need to compare these results with those observed in normal human controls adjusted for gender and for age groups.

These patients are first screened for the presence of acute or chronic severe diseases (cancer, cardiovascular, articular, et...). They then have genomic DNA extracted from pe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy-for-age subjects, as defined by Absence of acute infectious, traumatic or immunologic disease; Absence of severe chronic diseases Age and sex concordant with the stratification of patients from a longitudinal cohort of early inflammatory arthritis (EUPA)
  • Exclusion Criteria:
  • History of cancer (except a single episode of non-melanocytic skin cancer) Severe cardiovascular disease (i.e. difficult to control or requiring multiple drugs) Chronic infection Inflammatory arthritis Severe high blood pressure or diabetes (i.e. difficult to control or requiring multiple drugs) Any severe disease affecting function or difficult to control or requiring multiple drugs

About Université De Sherbrooke

The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.

Locations

Sherbrooke, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Gilles Boire, MD, MSc

Principal Investigator

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials